The US Food and Drug Administration (FDA) has granted 510(k) clearance for Idev Technologies’ 6 French (6Fr) Supera Veritas transhepatic biliary stent system.

The new lower profile system is available in two catheter lengths, 80cm and 120cm, and is designed for palliative treatment of biliary strictures produced by malignant neoplasms.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Idev Technologies president and CEO Christopher Owens said that the new 6Fr system allows for improved ease of use, trackability and control of stent deployment.

The company plans to launch the Supera Veritas transhepatic biliary stent system in January 2012.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact